Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Acidosis and Tumor Progression

Investigating the Molecular Mechanisms of Cancer

Is Cancer a Metabolic Disorder?

Cancer Screening Considerations: Balancing the Benefits and Risks

Pediatric Cancer

Insights into Oncofertility

Overview of Cell Viability and Cytotoxicity

Cancer Pain Management

What Causes Cancer?

What is Cancer?

See more featured articles »

Assay for Monitoring and Treating Malignant Brain Tumors

Metastatic Migration in Cancer may be Influenced by Metabolism

Targeted Cancer Therapies

The Effects of Cancer on Family Life

What is the Tumor Microenvironment?

Myc Mutations and Cancer

Living with Cancer Pain

The Biochemistry of Breast Cancer Screening

Extracellular Vesicles as Floating Cancer Biomarkers

Why are Cancer Cell Lines Useful?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What Role do Biobanks Play in Cancer Research?

What is Cancer of Unknown Primary?

Transforming Cancer Care through Genomic Testing

Cancer Classification

Cancer History

Cancer Research

Hypoxia Markers and Their Importance

Microfluidic cancer treatment screen combined with flow cytometry

The Cancer Cell Surface Proteome as a Therapeutic Target

What is Tumorigenesis?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Insight into Cancer Vaccines

Cancer Glossary

What is Merkel Cell Carcinoma?

Cancer Management

British Pioneers in Cancer Biology

Caring for a Loved One with Cancer

Cancer Prognosis

Cutaneous Manifestations of Internal Malignancy

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What is Immunochemotherapy?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Diagnosis

Cancer Epidemiology

Cancer Pain

Cancer Pathophysiology

Using Biomarkers to Detect Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Prevention: Lowering your Risk

Secondary Brain Cancer

Hot vs Cold: the differences between tumor types

Effects of Social and Economic Deprivation on Cancer Mortality

CDK9 and Cancer

Secondary Lung Cancer

Cancer Symptoms

TARDIS: The Improved Method of Detecting Breast Cancer

Latest Cancer News and Research

Lifestyle habits predict long-term health better than cancer treatment history

Healthy lifestyle habits are crucial for childhood cancer survivors, reducing risks of chronic conditions and improving quality of life more than treatments.

2 Jun 2026

New magnetic particle imaging ensures precision cell therapy injection tracking

Scientists at Johns Hopkins Medicine say they used a form of magnetic imaging to track cell therapy injections commonly used to treat certain autoimmune diseases and cancers.

2 Jun 2026

E-cigarette flavors and device type drive the biological effects of vaping

People who vape regularly show altered activity in 3,124 genes across the genome compared with people who do not smoke or vape.

1 Jun 2026

Pediatric experts reveal the 10 research areas set to shape child health

Pediatric research leaders identified 10 high-promise areas likely to shape child health over the next 5 to 10 years, including genomics, mental health, vaccines, artificial intelligence, perinatal medicine, precision therapeutics, health equity, nutrition, environmental health, and cancer treatment. The paper argues that these opportunities will only translate into better outcomes if pediatric research receives sustained funding, public trust, workforce support, advocacy, and equitable implementation.

1 Jun 2026

New PET tracer offers a powerful tool for kidney cancer staging

A new PET tracer targeting carbonic anhydrase IX (CAIX) has demonstrated exceptional sensitivity and high tumor-to-background contrast in detecting clear cell renal cell carcinoma (ccRCC), according to early clinical research.

1 Jun 2026

PromptSE AI predicts drug side effects by reasoning through biological clues

PromptSE uses structured LLM prompting to generate pharmacologically relevant side-effect representations, then feeds them into deep learning models to predict drug-side effect associations. In benchmark testing, PromptSE improved prediction performance, while PromptSE+ further boosted results by adding multi-modal drug information and graph-based refinement for sparse data.

1 Jun 2026

Genetic testing finds breast cancer risks that standard screening models miss

Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed by clinical risk models, even when polygenic risk scores were added. In the WISDOM Study analysis, fewer than 1% of high-penetrance variant carriers would have received the same high-risk screening recommendation using clinical plus polygenic risk alone.

1 Jun 2026

Brazilian study links TP53 mutations to poor lung cancer prognosis

Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with different mutations that vary according to factors such as smoking and ethnicity.

1 Jun 2026

Mature intestinal cells regain stem cell behavior to trigger tumor growth

In a groundbreaking study, Stevens researchers show how colorectal cancers can evolve from mature intestinal cells that revert to stem cells.

1 Jun 2026

Study shows how HIV leads to chronic pain

Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci paper, Hui-Lin Pan, from The University of Texas MD Anderson Cancer Center, and colleagues used mice to explore how HIV leads to chronic pain.

1 Jun 2026

New atlas provides unprecedented overview of dendritic cell diversity across cancers

Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells.

1 Jun 2026

Targeting microRNA pathway helps overcome cancer immunotherapy resistance

Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transformed cancer treatment.

1 Jun 2026

Study evaluates statistical models for estimating breast cancer risk

Researchers from Trinity College Dublin, St James's Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.

1 Jun 2026

Vaccine and drug combination cuts melanoma recurrence by half

The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence by 49 percent, a new study shows.

1 Jun 2026

Understanding mitochondrial biology in alcohol-associated liver disease and cancer

For decades, giant mitochondria-known as megamitochondria-have been recognized in liver biopsies from patients with alcohol-associated liver disease (ALD).

1 Jun 2026

Healthy lifestyles reduce cardiovascular risks for childhood cancer survivors

Healthy lifestyles can reduce the risk of cardiovascular disease and other complications in childhood cancer survivors.

1 Jun 2026

Laverock Therapeutics awarded in excess of £2.2 M through two innovation grants to support AI-powered platform development and to expand therapeutic programs outside of oncology

Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced it has been awarded two new grants totaling in excess of £2.2 M to support the next generation of its gene-control platform development, and expansion into additional non-oncology therapeutics areas.

From Laverock Therapeutics 1 Jun 2026